With over 25 years of experience in his field, he has been instrumental in preparing products for insertion into devices that facilitate infusion processes, ensuring patients' ease of use.
BOCA RATON, FL, July 16, 2024 /24-7PressRelease/ -- Abe Germansderfer has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Mr. Germansderfer, a distinguished professional in the biotechnology and pharmaceutical industries, currently serves as the senior director of combination product process development at Telavant. With over 25 years of experience in his field, he has been instrumental in preparing products for insertion into devices that facilitate infusion processes, ensuring patients' ease of use. Additionally, Mr. Germansderfer oversees the necessary steps for Food and Drug Administration approval to ensure products are market-ready.
Since joining his organization in 2023, Mr. Germansderfer has achieved remarkable success by developing an anti-inflammatory molecule targeting the TL1A protein, creating an anti-TL1A antibody. This groundbreaking development has significantly benefited patients with gastrointestinal diseases, such as Inflammatory Bowel Disease (IBD) and Crohn's Disease, with many experiencing full remission.
Before joining Telavant, Mr. Germansderfer was the head of manufacturing science and technology at Charles River Laboratories from 2022 to 2023. He also succeeded as a senior quality director at Allogene Therapeutics between 2019 and 2022. Mr. Germansderfer's tenure at Scandinavian Health Limited Group as the senior director of process development between 2016 and 2019 also helped solidify his expertise in regulatory affairs and regulatory submissions. Among other noteworthy roles, he worked for Novartis in Switzerland from 2013 to 2016 as the global head of manufacturing science and technology, where he played a pivotal role in launching Cosentyx into the market.
Mr. Germansderfer's academic background includes a Bachelor of Science in biology in 1996 and a Master of Science in biotechnology in 1997 from Worcester Polytechnic Institute in Worcester, Massachusetts. His educational achievements have been fundamental to his professional success and have equipped him with the knowledge and skills necessary for his numerous contributions to the field.
Mr. Germansderfer attributes his success to his willingness to seize every opportunity that comes his way. This proactive approach has proven rewarding throughout his career and continues to drive his professional achievements today.
As he prepares for his future over the next few years, Mr. Germansderfer is eager to continue making a positive impact in the field. Beyond his work, he likes to travel and spend time with his family and dogs.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.
# # #